Related Experiment Video
Updated: Jun 16, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges - A Narrative
Fatimah Khoda1, Anne Chandidzura2, Rodney Sinclair3
1Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M6 8HD, UK.
Abstract:
New targeted therapeutic approaches (eg. biologics, small molecules) have significantly changed the management of inflammatory dermatology conditions in recent years. Alopecia areata (AA), a non-scarring autoimmune hair loss condition, is one of the latest diseases to benefit from these developments. Here we review traditional, new and evolving therapies for AA and highlight the benefits, challenges and uncertainties that come with these new options. We present various real-world data collection approaches currently available and introduce GRASS-UK/GRASS-International as a global collaborative network of prospective AA disease registers designed to study the longer-term safety and effectiveness of new AA therapies as they are introduced.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Accessory Structures of the Skin: Hair Growth and Types
Atherosclerosis III: Management
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Acne Infection
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
